Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1284, 2001-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Salmeterol/fluticasone propionate more cost effective in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 487, 2005-01 ,pp. :
Fluticasone propionate more cost effective than zafirlukast for asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 330, 2001-01 ,pp. :
Fluticasone propionate more cost effective than zafirlukast for asthma
Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. :
Better advantage with fluticasone propionate in persistent asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 291, 2000-01 ,pp. :
Mometasone matches fluticasone propionate in persistent asthma
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :